[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.0.26. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Comments, Opinions, and Brief Case Reports
March 12, 2001

Intranasal Tranexamic Acid Treatment for Severe Epistaxis in Hereditary Hemorrhagic Telangiectasia

Arch Intern Med. 2001;161(5):767-769. doi:

Hereditary hemorrhagic telangiectasia (HHT [Osler-Rendu-Weber disease]) is a dominantly inherited disease characterized by multiple telangiectatic lesions or arteriovenous malformations that may rupture and bleed. Symptoms vary according to the location of the lesions, but the skin, nasal mucosa, gastrointestinal tract mucosa, and pulmonary, cerebral, or hepatic circulation are commonly affected.1 The prevalence of HHT in Europe is 14 to 16 persons per 100 000 and may be rising. Epistaxis is both an early and very common manifestation of HHT affecting most patients and is often recurrent, severe, and resistant to treatment.2 We report a simple, safe, and efficacious treatment for recurrent severe epistaxis in HHT.

First Page Preview View Large
First page PDF preview
First page PDF preview
×